Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

02 Jul 2018

• By Joseph Haas, Eleanor Malone, and Kevin Grogan

Celgene makes play into RNA-expression correction via neuroscience partnership and equity investment with Skyhawk. Novartis’ Sandoz agreed to commercialize Adamis’ Symjepi, a competitor to EpiPen, in the US.

Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

More from Deals

More from Business